학술논문

EFAS/EAN survey on the influence of the COVID-19 pandemic on European clinical autonomic education and research.
Document Type
Academic Journal
Author
Fanciulli A; Department of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria. alessandra.fanciulli@i-med.ac.at.; Skorić MK; Department of Neurology, University Hospital Centre, Zagreb, Croatia.; Faculty of Electrical Engineering and Computing, University of Zagreb, Zagreb, Croatia.; Leys F; Department of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.; Carneiro DR; Department of Neurology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.; Neurology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; Campese N; Department of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.; Calandra-Buonaura G; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.; Camaradou J; Patient Partner of the EAN Scientific Panel for Autonomic Nervous System Disorders, London, UK.; Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.; Chiaro G; Autonomic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.; UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.; Cortelli P; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.; Falup-Pecurariu C; Department of Neurology, Faculty of Medicine, Transilvania University, Brasov, Romania.; Granata R; Department of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.; Guaraldi P; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Helbok R; Department of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.; Department of Neurology, Johannes Kepler University, Linz, Austria.; Hilz MJ; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Neurology, University Erlangen-Nuremberg, Erlangen, Germany.; Iodice V; Autonomic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.; UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.; Jordan J; German Aerospace Center, Cologne, Germany.; Medical Faculty, University of Cologne, Cologne, Germany.; Kaal ECA; Department of Neurology, Maasstad Ziekenhuis, Rotterdam, The Netherlands.; Kamondi A; Department of Neurology, National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary.; Department of Neurology, Semmelweis University, Budapest, Hungary.; Le Traon AP; Department of Neurology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.; Rocha I; Cardiovascular Autonomic Function Lab, Faculty of Medicine and CCUL, University of Lisbon, Lisbon, Portugal.; Sellner J; Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria.; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.; Senard JM; Institut des Maladies Métaboliques et Cardiovasculaires, INSERM U 1297, Toulouse, France.; Terkelsen A; Department of Neurology, Aarhus University Hospital and Danish Pain Research Center, Aarhus University, Aarhus, Denmark.; Wenning GK; Department of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.; Moro E; Division of Neurology, Grenoble Institute of Neuroscience, Grenoble Alpes University, CHU of Grenoble, Grenoble, France.; Berger T; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.; Thijs RD; Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands.; Struhal W; Department of Neurology, University Hospital Tulln, Karl Landsteiner University of Health Sciences, Tulln, Austria.; Habek M; Department of Neurology, University Hospital Centre, Zagreb, Croatia.; Department of Neurology, University of Zagreb, School of Medicine, Zagreb, Croatia.
Source
Publisher: Steinkopff Country of Publication: Germany NLM ID: 9106549 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-1560 (Electronic) Linking ISSN: 09599851 NLM ISO Abbreviation: Clin Auton Res Subsets: MEDLINE
Subject
Language
English
Abstract
Purpose: To understand the influence of the coronavirus disease 2019 (COVID-19) pandemic on clinical autonomic education and research in Europe.
Methods: We invited 84 European autonomic centers to complete an online survey, recorded the pre-pandemic-to-pandemic percentage of junior participants in the annual congresses of the European Federation of Autonomic Societies (EFAS) and European Academy of Neurology (EAN) and the pre-pandemic-to-pandemic number of PubMed publications on neurological disorders.
Results: Forty-six centers answered the survey (55%). Twenty-nine centers were involved in clinical autonomic education and experienced pandemic-related didactic interruptions for 9 (5; 9) months. Ninety percent (n = 26/29) of autonomic educational centers reported a negative impact of the COVID-19 pandemic on education quality, and 93% (n = 27/29) established e-learning models. Both the 2020 joint EAN-EFAS virtual congress and the 2021 (virtual) and 2022 (hybrid) EFAS and EAN congresses marked higher percentages of junior participants than in 2019. Forty-one respondents (89%) were autonomic researchers, and 29 of them reported pandemic-related trial interruptions for 5 (2; 9) months. Since the pandemic begin, almost half of the respondents had less time for scientific writing. Likewise, the number of PubMed publications on autonomic topics showed the smallest increase compared with other neurological fields in 2020-2021 and the highest drop in 2022. Autonomic research centers that amended their trial protocols for telemedicine (38%, n = 16/41) maintained higher clinical caseloads during the first pandemic year.
Conclusions: The COVID-19 pandemic had a substantial negative impact on European clinical autonomic education and research. At the same time, it promoted digitalization, favoring more equitable access to autonomic education and improved trial design.
(© 2023. The Author(s).)